Product Name:1-(morpholin-4-yl)cyclobutane-1-carboxylic acid

IUPAC Name:1-(morpholin-4-yl)cyclobutane-1-carboxylic acid

CAS:1250633-44-3
Molecular Formula:C9H15NO3
Purity:95%+
Catalog Number:CM462339
Molecular Weight:185.22

Packing Unit Available Stock Price($) Quantity
CM462339-1g in stock ȦƱƱ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1250633-44-3
Molecular Formula:C9H15NO3
Melting Point:-
Smiles Code:OC(=O)C1(CCC1)N1CCOCC1
Density:
Catalog Number:CM462339
Molecular Weight:185.22
Boiling Point:
MDL No:MFCD16744859
Storage:

Category Infos

Morpholines
Morpholine contains secondary amine groups and has all the typical reactive characteristics of secondary amine groups. It can react with inorganic acids to form salts, and react with organic acids to form salts or amides, which can be subjected to alkylation reaction, and can also be reacted with ethylene oxide, ketone or Willgerodt reaction. Morpholine is a six-membered ring containing oxygen and nitrogen, and its alkalinity is much lower than that of its parent piperidine. The marketed morpholine drugs are mainly distributed in the fields of tumors, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system diseases, infectious diseases and mental disorders.
morpholine price
if you are interested in morpholine price, please feel free to contact us. More information of our products will be forwarded to you upon receipt of your specific inquiry.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.